Table 3

Resistance profiles of major Gram-negative bacteria from 27 VAP patients in a public hospital of northern Brazil
Microorganism N Antibioticsa/No. of resistant strains (%)
PIP FEP ATM CAZ CIP MEM GEN IPM TZP TOB AMK
P. aeruginosa 11 5 (45.4) 6 (54.5) 4 (36.4) 6 (54.5) 5 (45.4) 5 (45.4) 4 (36.4) 5 (45.4) 4 (36.4) 4 (36.4) 2 (18.2)
Acinetobacter spp. 11 7 (63.6) 7 (63.6) 8 (72.7) 7 (63.6) 7 (63.6) 7 (63.6) 5 (45.4) 6 (54.5) 5 (45.4) 2 (18.2) 3 (27.3)
Enterobacteriaceaeb 8 7 (87.5) 3 (37.5) 3 (37.5) 2 (25.0) 3 (37.5) 1 (12,5) 4 (50.0) 1 (12,5) 1 (12,5) 4 (50.0) 1 (12,5)
Total 30 19 (63.3) 16 (53.3) 15 (50.0) 15 (50.0) 15 (50.0) 13 (43.3) 13 (43.3) 12 (40.0) 10 (33.3) 10 (33.3) 6 (20.0)

a PIP: Piperacillin; ATM: Aztreonam; FEP: Cefepime; CAZ: Ceftazidime; CIP: Ciprofloxacin; MEM: Meropenem; GEN: Gentamicin; IPM: Imipenem; TZP: Piperacillin/Tazobactam; TOB: Tobramycin; AMK: Amikacin. bKlebsiella (5), Enterobacter (2), and Escherichia (1).

Resende et al.

Resende et al. BMC Infectious Diseases 2013 13:119   doi:10.1186/1471-2334-13-119

Open Data